About Neogen
Neogen is a company based in Lansing (United States) founded in 1982 was acquired by Kersia in April 2025. Neogen has raised $700 thousand across 1 funding round from investors including Kersia and Innovative Ventures. The company has 2,970 employees as of May 31, 2024. Neogen has completed 13 acquisitions, including Abtek Biologicals, Adgen and Delf. Neogen offers products and services including AccuPoint®, Petrifilm®, and Igenity®. Neogen operates in a competitive market with competitors including Parse Biosciences, Qiagen, Biofidelity, Fluent BioSciences and LGC, among others.
- Headquarter Lansing, United States
- Employees 2970 as on 31 May, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neogen Corporation
-
Annual Revenue
$894.66 M (USD)-3.2as on May 31, 2025
-
Net Profit
-$1.09 B (USD)-11491.59as on May 31, 2025
-
EBITDA
$135.09 M (USD)-32as on May 31, 2025
-
Total Equity Funding
$700 K (USD)
in 1 rounds
-
Latest Funding Round
$700 K (USD), Series A
Jul 01, 1988
-
Investors
Kersia
& 1 more
-
Employee Count
2970
as on May 31, 2024
-
Investments & Acquisitions
Abtek Biologicals
& 12 more
-
Acquired by
Kersia
(Apr 23, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Neogen
Neogen is a publicly listed company on the NASDAQ with ticker symbol NEOG in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Neogen
Neogen offers a comprehensive portfolio of products and services, including AccuPoint®, Petrifilm®, and Igenity®.
ATP detection swab for surface hygiene testing
Plates for rapid bacterial enumeration in food samples
Genomic profiles for livestock genetic trait analysis
People of Neogen
Unlock access to complete
Unlock access to complete
Leadership Team
25 people
Software Development Team
18 people
Sales and Marketing
12 people
Operations Team
10 people
Product Management Team
10 people
Senior Team
7 people
Legal and Compliance
7 people
Finance and Accounting
6 people
Unlock access to complete
Funding Insights of Neogen
Neogen has successfully raised a total of $700K through 1 strategic funding round. The most recent funding activity was a Series A round of $700 thousand completed in July 1988. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Neogen
Neogen has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Kersia and Innovative Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Provider of food safety testing services
|
Locked | Locked | Locked |
Investor details for Neogen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neogen
Neogen has strategically engaged in corporate development activities, having acquired 13 companies. Notable acquisitions include Abtek Biologicals, Adgen and Delf.
Investment portfolio details for Neogen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Genomics services are provided for the livestock industry.
|
Locked | Locked | 2011 | Locked | |
|
Genetic evaluations and data management services for livestock are offered.
|
Locked | Locked | 2011 | Locked | |
|
Animal genomics laboratory services are provided worldwide.
|
Locked | Locked | 2008 | Locked |
Complete acquisition details for Neogen
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Neogen
Detailed financials for Neogen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neogen Comparisons
Peer comparison for Neogen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neogen
Neogen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Parse Biosciences, Qiagen, Biofidelity, Fluent BioSciences and LGC, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
RNA-sequencing transcriptome kits for health data analysis are developed.
|
|
| Locked | Locked | Locked |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| Locked | Locked | Locked |
Molecular diagnostic assays are developed for target DNA sequence detection.
|
|
| Locked | Locked | Locked |
Proprietary reagents for single-cell genetic analysis are developed.
|
|
| Locked | Locked | Locked |
Molecular biology reagents and services are supplied to biotech industries.
|
Detailed competitors of Neogen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neogen
Complete news archive for Neogen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neogen
Neogen was founded in 1982 and raised its 1st funding round 6 years after it was founded.
Neogen is headquartered in Lansing, United States. It is registered at Lansing, Michigan, United States.
Neogen is a funded company, having raised a total of $700K across 1 funding round to date.
As of May 31, 2024, the latest employee count at Neogen is 2,970.
Annual revenue of Neogen is $894.66M as on May 31, 2025.
Neogen was founded in 1982 in Lansing, United States, and operates in the biotechnology sector focused on food and animal safety. Dehydrated culture media and diagnostic kits are produced by the Food Safety Division for detecting foodborne bacteria, natural toxins, genetic modifications, allergens, drug residues, plant diseases, and sanitation issues. The Animal Safety Division provides diagnostics, veterinary instruments, pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.
Neogen's top competitors include Qiagen, Paragon Genomics and Parse Biosciences.
Neogen offers AccuPoint®, Petrifilm®, and Igenity®.
Yes, Neogen is publicly traded on NASDAQ under the ticker symbol NEOG.
Neogen has made 13 acquisitions, including Abtek Biologicals, Adgen, and Delf.
Neogen has 2 investors. Key investors include Kersia, and Innovative Ventures.
The ticker symbol of Neogen is NEOG on NASDAQ.